NCCN Oncology Research Program (ORP)

NCCN ORP Mission Statement

The NCCN ORP fosters innovation and knowledge discovery that improve the lives of patients with cancer.

Guiding Principles:

1. Study both FDA-approved and investigational agents/devices, to seek novel enhanced, effective, and efficient cancer therapy.
2. Develop new insights into cancer care delivery outcomes and quality, as well as identify solutions to barriers affecting optimal cancer management.
3. Increase opportunities for NCCN Member Institution faculty to participate in oncologic investigation and support those who are, or will become, leaders in cancer research.
4. Demonstrate that constructive, appropriate, and transparent collaboration between academia and industry results in valuable knowledge and improved cancer management.
5. Ensure the dissemination of knowledge gained through the program to the medical community at large through presentations at meetings and/or publication in peer-reviewed journals.

Current Opportunities

NCCN and Novartis Quality Improvement Project: Patient-Centered Quality Improvement Across the Breast Cancer Continuum – Proposals Due by Tuesday, July 15, 2025, by 5:00 pm ET. Open to NCCN Member Institutions in the United States.

Now Accepting Abstracts for the 2026 NCCN Annual Conference General Poster Session - Submit an abstract by Wednesday, October 29, 2025, 11:59 PM ET.